TMO
42
-6
PAYX
48
-6
HSY
31
-6
FMC
23
-3
CVX
43
-3
KLAC
38
-6
SEE
53
3
INTC
41
4
ADP
65
-3
SNA
70
-5
MAR
63
-5
FIS
51
-4
ROST
57
-3
TJX
62
-2
GILD
47
-8
NWSA
62
-7
YUM
43
-6
ALLE
37
-4
NI
72
4
CTAS
53
-3
TMO
42
-6
PAYX
48
-6
HSY
31
-6
FMC
23
-3
CVX
43
-3
KLAC
38
-6
SEE
53
3
INTC
41
4
ADP
65
-3
SNA
70
-5
MAR
63
-5
FIS
51
-4
ROST
57
-3
TJX
62
-2
GILD
47
-8
NWSA
62
-7
YUM
43
-6
ALLE
37
-4
NI
72
4
CTAS
53
-3
Financhill
Back

iShares MSCI Emerging Markets ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
30

EEM
iShares MSCI Emerging Markets ETF

Last Price:
42.95
Seasonality Move:
3.89%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
30
iShares MSCI Emerging Markets ETF (EEM) is a Sell

Is iShares MSCI Emerging Markets ETF a Buy, Sell or Hold?

  • The current iShares MSCI Emerging Markets ETF [EEM] share price is $42.95. The Score for EEM is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • EEM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EEM Stock Price Chart

What is iShares MSCI Emerging Markets ETF's stock price today?

  • The iShares MSCI Emerging Markets ETF share price today is $42.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EEM is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.5 Sell
Relative Strength Index (14 RSI): 34.79 Sell
Chaikin Money Flow: -7278206 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.98 - 45.72) Sell
Bollinger Bands (100): (42.3 - 45.4) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.01 Sell
20-day SMA: 44.65 Sell
50-day SMA: 44.84 Sell
200-day SMA: 42.58 Buy
8-day EMA: 43.74 Sell
20-day EMA: 44.43 Sell
50-day EMA: 44.53 Sell
200-day EMA: 42.84 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares MSCI Emerging Markets ETF Earnings Growth & EEM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

iShares MSCI Emerging Markets ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):